This variation is influenced by factors, such as the histological type of the cancer, the status of the epidermal growth factor receptor (EGFR) mutation, and the stage of the disease (Berghoff et al. 2016; Nayak et al. 2012; Goncalves et al. 2016; Wang et al. 2017; Zhang et al. 2020; Rizzoli et al. 2013). Here, EGFR is linked to cancer.